IGF-1 LR3 takes one of the body’s most powerful muscle-building signals and makes it last. Native IGF-1 is a master regulator of growth and repair, but it disappears from the bloodstream within minutes. IGF-1 LR3 is engineered to stay active for a full day, which is why it has become a go-to compound for studying muscle growth, recovery, and tissue regeneration.
What IGF-1 LR3 is
IGF-1 LR3 (Long Arginine 3-IGF-1) is a synthetic, lengthened version of human insulin-like growth factor 1. It carries two key modifications: an extra 13 amino acids on one end for stability, and an arginine substitution at the third position. Together these dramatically reduce how tightly it binds to the IGF-binding proteins that normally sweep IGF-1 out of circulation. The payoff is a half-life of roughly 20 to 30 hours, compared with minutes for native IGF-1, which means sustained signalling from a single dose.
What the research shows
IGF-1 LR3 has become one of the most-used tools in muscle biology research because it stays active long enough to produce clear effects. In laboratory studies it strongly drives the proliferation and differentiation of muscle cells and activates satellite cells, the resident stem cells that repair and grow muscle tissue. Classic research on IGF-1 and muscle hypertrophy showed that roughly half of the growth effect depends on those satellite cells, underlining how central this pathway is to building muscle.
The compound’s reach goes beyond muscle. Because IGF-1 receptors appear in many tissues, research has documented effects on bone, collagen synthesis, and nerve regeneration as well, which is why IGF-1 LR3 is often studied alongside recovery peptides like BPC-157 and TB-500 for full-spectrum tissue repair. It also enhances the uptake of glucose and amino acids into tissue, supporting the nutrient delivery that growth depends on.
How it works
IGF-1 LR3 acts through the IGF-1 receptor (IGF-1R), a tyrosine kinase found on muscle, bone, and other tissues. When it binds, it switches on two major signalling routes: the PI3K/Akt/mTOR pathway, which drives protein synthesis and cellular growth, and the MAPK/ERK pathway, which drives cell proliferation and differentiation. Because the LR3 modifications keep it from being captured by binding proteins, it engages those receptors steadily over many hours, producing a stronger and more sustained anabolic signal than native IGF-1 ever could.
Quick facts
| IGF-1 LR3 | |
|---|---|
| Type | Synthetic lengthened analog of human IGF-1 |
| Modifications | Extra 13 amino acids plus an Arg3 substitution |
| Best known for | Muscle growth, recovery, and tissue repair |
| Key mechanism | IGF-1 receptor activation (Akt/mTOR and ERK pathways) |
| Half-life | Roughly 20 to 30 hours (vs minutes for native IGF-1) |
| Often paired with | BPC-157, TB-500 |
| Form | Lyophilized powder, reconstituted before use |
What to look for when buying
With a growth factor this potent, purity and correct sequence are everything. Look for a Certificate of Analysis (COA) from third-party testing and an HPLC-MS purity figure of 99% or higher. Every batch of Marek Pharma’s IGF-1 LR3 is HPLC-MS tested with a COA, lyophilized for stability, and ships from within Canada.
References
- Long R3 IGF-1: structure, reduced IGFBP binding, and extended half-life (growth factor engineering literature).
- IGF-1 signalling through IGF-1R via the PI3K/Akt/mTOR and MAPK/ERK pathways in skeletal muscle.
- Satellite cell contribution to IGF-1-induced muscle hypertrophy (muscle physiology research).
For laboratory and research use only.